Thor Medical ASA (FRA:8NN)

Market Cap	131.48M
Revenue (ttm)	8.42K
Net Income (ttm)	-4.96M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.3415
Previous Close	0.3325
Day's Range	0.3415 - 0.3415
52-Week Range	0.1570 - 0.4050
Beta	n/a
RSI	72.72
Earnings Date	Feb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2009
• Employees: 9
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8NN

Financial Performance

Financial numbers in NOK